These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8497339

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments.
    Mattingly BA, Rowlett JK, Ellison T, Rase K.
    Pharmacol Biochem Behav; 1996 Mar; 53(3):481-6. PubMed ID: 8866944
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions.
    Mailman RB, Schulz DW, Lewis MH, Staples L, Rollema H, Dehaven DL.
    Eur J Pharmacol; 1984 May 18; 101(1-2):159-60. PubMed ID: 6235121
    [No Abstract] [Full Text] [Related]

  • 31. Region-specific activation of the AMPK system by cocaine: The role of D1 and D2 receptors.
    Xu S, Kang UG.
    Pharmacol Biochem Behav; 2016 May 18; 146-147():28-34. PubMed ID: 27132751
    [Abstract] [Full Text] [Related]

  • 32. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice.
    O'Neill MF, Shaw G.
    Psychopharmacology (Berl); 1999 Aug 18; 145(3):237-50. PubMed ID: 10494572
    [Abstract] [Full Text] [Related]

  • 33. Behavioral stereotypies induced by "binge' cocaine administration are independent of drug-induced increases in corticosterone levels.
    Spangler R, Zhou Y, Schlussman SD, Ho A, Kreek MJ.
    Behav Brain Res; 1997 Jul 18; 86(2):201-4. PubMed ID: 9134155
    [Abstract] [Full Text] [Related]

  • 34. Dopamine D1 and D2 receptor antagonism during development alters later behavior in zebrafish.
    Oliveri AN, Levin ED.
    Behav Brain Res; 2019 Jan 01; 356():250-256. PubMed ID: 30172631
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats.
    Ranaldi R, Beninger RJ.
    Psychopharmacology (Berl); 1993 Jan 01; 113(1):110-8. PubMed ID: 7862816
    [Abstract] [Full Text] [Related]

  • 38. Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
    Cheung TH, Bezzina G, Hampson CL, Body S, Fone KC, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2007 Dec 01; 195(2):213-22. PubMed ID: 17668188
    [Abstract] [Full Text] [Related]

  • 39. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA, Himmler C, Bonta T, Rice LL.
    Psychopharmacology (Berl); 1998 Dec 01; 140(4):387-97. PubMed ID: 9888612
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.